Key discussion points from MASCC 2016
Key messages on prostate cancer treatment from BOPA 2017
Treating delirium with antipsychotics
The importance of biomarkers to optimize treatment with immunotherapy for melanoma
What does the earlier application of immune-oncology agents mean for urological cancer teams?